Effect of maternal dexamethasone administration on daily fetal movement count and its correlation with Doppler studies and cardiotocography

Background: Decreased fetal movements is a frequent reason for unplanned consultations through the third trimester ranging between 4% and 16% in various populations it is often a sign of fetal compromise and associated with severe outcomes such as fetal growth restriction, preterm birth and fetal death therefore it is important to question the effect of maternal dexamethasone administration for fetal well-being and its relation on decreased fetal movement which is detected by Doppler studies and cardiotocography. Methods: The current study was performed on 220 pregnant women with gestational age between 28-34 weeks who received antenatal dexamethasone at Ain Shams university hospitals.Results: Regarding fetal movements, there was significant decrease in fetal movement at the 24th hour (Day 2) after 1st and 2nd doses of dexamethasone then re-increased at 48th hour and 72nd hour but still significantly lower than baseline.Conclusions: Administration of dexamethasone had no harmful effects on the fetuses or the mothers, except for a transient decrease of fetal movements in only after 24 hours of the first dose.

Host plant mediates foraging behavior and mutual interference among adult Stethorus gilvifrons (Coleoptera: Coccinellidae) preying on Tetranychus urticae (Acari: Tetranychidae)

Citation: Bayoumy, M. H., Osman, M. A., & Michaud, J. P. (2014). Host plant mediates foraging behavior and mutual interference among adult Stethorus gilvifrons (Coleoptera: Coccinellidae) preying on Tetranychus urticae. Retrieved from http://krex.ksu.eduPhysical plant characteristics can influence predator foraging and their behavioral responses to each other. This study examined the searching efficiency and functional response of adult female Stethorus gilvifrons Mulsant foraging for Tetranychus urticae Koch (Acari: Tetranychidae) on castor bean, common bean, and cucumber leaves. Experiments conducted on leaf discs in arenas for 12 h revealed a type II functional response for S. gilvifrons on all host plants. Per capita searching efficiency and killing power decreased with increasing predator density on all plants, but most notably on common bean, the plant with the highest prey consumption rates, due to greater mutual interference. Attack rates were highest on common bean and lowest on castor bean, whereas handling times were shortest on common bean and longest on cucumber, such that the daily predation rate was maximal on common bean. Host plant interacted with predator and prey densities to affect searching efficiency and functional response, the differences in mite consumption among host plants increasing with predator and prey densities. The waxy layers of castor bean leaves and high trichome counts of cucumber leaves appeared to reduce predator foraging efficiency. Thus, the efficacy of S. gilvifrons against T. urticae is likely to be greatest on plants such as Phaeseolus vulgaris L. that have relatively smooth leaves

NDM-559: EXPERIMENTAL INVESTIGATION OF TWO-WAY CONCRETE PANELS EXPOSED TO IMPACT LOAD

Protecting existing and new structures from potential terrorist attacks and accidents is becoming an essential consideration in the design of most structures. Building façade is the first layer exposed to external loading, thus it acts as the first line of defence against external loads. Precast concrete panels are mostly used in external building\u27s façade for modern construction, and therefore their resistance to other dynamic loads such as impact load needs further evaluation. This paper presents the results of an experimental research on two-way reinforced concrete panels as well as thin ferrocement concrete panels under impact loading. The impact test apparatus used is versatile enough to test large variety of specimens modeling façade units. The performance of the panels under impact load is evaluated in terms of: the failure mode; the maximum impact loads sustained by the panels; the number of impact loads up to failure; the maximum load transmitted to the supporting frame; and the strain induced in the panels. The effect of the different design parameters including the reinforcement amount, spacing and location across the panel thickness on the dynamic response of the panel to impact load are considered. Results clearly showed the significant effect of reinforcement on the overall resistance to impact loading. This research outcomes provide a better understanding of the performance of concrete panels under impact loading that can help enhancing structural design under such loads

Titrated Misoprostol Versus Dinoprostone for Labor Induction

Background: Misoprostol is as effective as dinoprostone for labor induction with low cost and temperature stability.Aim: This study designed to compare titrated misoprostol regarding its safety and efficacy with dinoprostone for induction of labor.Subjects and Methods: Women with a single pregnancy, above 37 weeks’ gestation, cephalic presentation, modified Bishop’s score <8, and not in labor with reassuring fetal heart rate, admitted for labor induction enrolled in this randomized controlled study. Studied women were randomized into; Group I: received oral misoprostol titrated in sterile water (200 μg tablet was dissolved in 200 ml sterile water [1 μg/ml]), starting dose of 20 μg misoprostol required, given every 2 h, and stopped if adequate contractions obtained and Group II: received vaginal dinoprostone tablet maximum two doses followed by augmentation of labor by oxytocin ± amniotomy if there is no uterine contractions after two doses of dinoprostone. In Group I, if the contractions were inadequate after two doses of oral titrated misoprostol (20 μg [20 ml]), the starting dose increased to 40 μg (40 ml), escalating the dose from 5 to 10 ml (45–50 μg), and 20 ml (60 μg) maximum ± amniotomy. If the uterine contractions were adequate, the next dose of misoprostol or dinoprostone was omitted. Statistical analysis done using Student’s t‑test for quantitative data and Chi‑square test for qualitative data.Results: Induction‑to‑delivery time was significantly longer in misoprostol than dinoprostone group (975 vs. 670 min, respectively), (P = 0.01). About 20.2% (21/104) of women in misoprostol group did not deliver vaginally within 24 h compared to 7.4% (8/108) in dinoprostone group (significant difference, P = 0.01). Augmentation of labor was significantly high in dinoprostone (37.96% [41/108]) compared to misoprostol group (10.6% [11/104]) (P < 0.01).Conclusion: Titrated misoprostol for induction of labor seems to be associated with significantly longer induction‑to‑delivery time, low incidence of vaginal birth within 24 h, and less need for augmentation of labor compared to vaginal dinoprostone.KEY WORDS: Dinoprostone, labor induction, titrated misoprosto

Tpeak-Tend, Tpeak-Tend/QT ratio and Tpeak-Tend dispersion for risk stratification in Brugada Syndrome:A systematic review and meta-analysis

Background: Brugada syndrome is an ion channelopathy that predisposes affected subjects to ventricular tachycardia/fibrillation (VT/VF), potentially leading to sudden cardiac death (SCD). Tpeak-Tend intervals, (Tpeak-Tend)/QT ratio and Tpeak-Tend dispersion have been proposed for risk stratification, but their predictive values in Brugada syndrome have been challenged recently. Methods: A systematic review and meta-analysis was conducted to examine their values in predicting arrhythmic and mortality outcomes in Brugada Syndrome. PubMed and Embase databases were searched until 1 May 2018, identifying 29 and 57 studies. Results: Nine studies involving 1740 subjects (mean age 45 years old, 80% male, mean follow-up duration was 68 ± 27 months) were included. The mean Tpeak-Tend interval was 98.9 ms (95% CI: 90.5-107.2 ms) for patients with adverse events (ventricular arrhythmias or SCD) compared to 87.7 ms (95% CI: 80.5-94.9 ms) for those without such events, with a mean difference of 11.9 ms (95% CI: 3.6-20.2 ms, P = 0.005; I2 = 86%). Higher (Tpeak-Tend)/QT ratios (mean difference = 0.019, 95% CI: 0.003-0.036, P = 0.024; I2 = 74%) and Tpeak-Tend dispersion (mean difference = 7.8 ms, 95% CI: 2.1-13.4 ms, P = 0.007; I2 = 80%) were observed for the event-positive group. Conclusion: Tpeak-Tend interval, (Tpeak-Tend)/QT ratio and Tpeak-Tend dispersion were higher in high-risk than low-risk Brugada subjects, and thus offer incremental value for risk stratification

Safety of Thioguanine in Pediatric Inflammatory Bowel Disease:A Multi-Center Case Series

Thioguanine (TG) has been shown as a safe alternative in adults with inflammatory bowel disease (IBD) who did not tolerate conventional thiopurines [azathioprine (AZA)/mercaptopurine]. However, data in pediatric IBD are scarce. Therefore, we aimed to assess the safety of TG as maintenance therapy. METHODS: A retrospective, multicenter cohort study of children with IBD on TG was performed in the Netherlands. TG-related adverse events (AE) were assessed and listed according to the common terminology criteria for AE. RESULTS: Thirty-six children with IBD (median age 14.5 years) on TG (median dose 15 mg/day) were included in 6 centers. Five AE occurred during follow-up [pancreatitis (grade 3), hepatotoxicity (grade 3) (n = 2), Clostridium difficile infection (grade 2), and abdominal pain (grade 2)]. All patients (n = 8) with a previously AZA-induced pancreatitis did not redevelop pancreatitis on TG. CONCLUSIONS: In pediatric IBD, TG seems a safe alternative in case of AZA-induced pancreatitis. Further research assessing long-term TG-related safety and efficacy is needed

Selenium and Lung Cancer: A Systematic Review and Meta Analysis

Selenium is a natural health product widely used in the treatment and prevention of lung cancers, but large chemoprevention trials have yielded conflicting results. We conducted a systematic review of selenium for lung cancers, and assessed potential interactions with conventional therapies.Two independent reviewers searched six databases from inception to March 2009 for evidence pertaining to the safety and efficacy of selenium for lung cancers. Pubmed and EMBASE were searched to October 2009 for evidence on interactions with chemo- or radiation-therapy. In the efficacy analysis there were nine reports of five RCTs and two biomarker-based studies, 29 reports of 26 observational studies, and 41 preclinical studies. Fifteen human studies, one case report, and 36 preclinical studies were included in the interactions analysis. Based on available evidence, there appears to be a different chemopreventive effect dependent on baseline selenium status, such that selenium supplementation may reduce risk of lung cancers in populations with lower baseline selenium status (serum<106 ng/mL), but increase risk of lung cancers in those with higher selenium (≥ 121.6 ng/mL). Pooling data from two trials yielded no impact to odds of lung cancer, OR 0.93 (95% confidence interval 0.61-1.43); other cancers that were the primary endpoints of these trials, OR 1.51 (95%CI 0.70-3.24); and all-cause-death, OR 0.93 (95%CI 0.79-1.10). In the treatment of lung cancers, selenium may reduce cisplatin-induced nephrotoxicity and side effects associated with radiation therapy.Selenium may be effective for lung cancer prevention among individuals with lower selenium status, but at present should not be used as a general strategy for lung cancer prevention. Although promising, more evidence on the ability of selenium to reduce cisplatin and radiation therapy toxicity is required to ensure that therapeutic efficacy is maintained before any broad clinical recommendations can be made in this context